🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy

RecruitingNAAges 40 Years - anyAllThe University of Hong Kong
NCT06495645 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged 40 or older * Scheduled for elective upper endoscopy Exclusion Criteria: * Pregnant women, * Inability to provide written informed consent * Prior gastrectomy, and * Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses
💊

What it tests

  • AI-assisted upper gastrointestinal endoscopy
📍

Where

1 site
Queen Mary Hospital, the University of Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy